NCT04615442 (ECV) is a NA clinical trial of Epihunter in Absence Seizures, sponsored by Epihunter NV.

Who is sponsoring NCT04615442?

NCT04615442 is sponsored by Epihunter NV.

What drugs are being tested in NCT04615442?

Interventions in NCT04615442: Epihunter.

What condition does NCT04615442 study?

NCT04615442 studies Absence Seizures, Absence Epilepsy.

Is NCT04615442 still recruiting?

NCT04615442 is currently completed. Last updated 4 April 2022.

Last reviewed 2022-04-04 · How we verify

NCT04615442: ECV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ECV - Epihunter Clinical Validation

Completed NA Last updated 4 April 2022

What this trial tests

NA trial testing Epihunter in Absence Seizures in 102 participants. Completed in 31 December 2021.

Timeline

1 May 2020

Primary endpoint
28 June 2021

31 December 2021

Quick facts

Lead sponsor	Epihunter NV
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	102
Start date	1 May 2020
Primary completion	28 June 2021
Estimated completion	31 December 2021
Sites	4 locations across Belgium, Denmark, Georgia, United States

Drugs / interventions tested

Epihunter

Conditions studied

Absence Seizures — all drugs for Absence Seizures →
Absence Epilepsy — all drugs for Absence Epilepsy →

Sponsor

Epihunter NV

Who can join

4 and older, any sex, with Absence Seizures or Absence Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective study is to validate a wearable EEG seizure detection solution compared to video EEG. Subjects that undergo a clinical video EEG are asked to additionally wear a wearable EEG headband for up to 2 periods of 4h during the video EEG.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Automated detection of absence seizures using a wearable electroencephalographic device: a phase 3 validation study and feasibility of automated behavioral testing.
Japaridze G, Loeckx D, Buckinx T, Armand Larsen S, et al · · 2023 · cited 34× · PMID 35176173 · DOI 10.1111/epi.17200

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04615442 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Epihunter NV
Last refreshed: 4 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04615442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing